Dr. Bossuyt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-726-2967
Education & Training
Brigham and Women's HospitalFellowship, Cytopathology, 2006 - 2007
Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2002 - 2005
Vrije Universiteit BrusselsClass of 2002
Certifications & Licensure
MA State Medical License 2005 - 2025
NH State Medical License 2023 - 2025
CT State Medical License 2007 - 2019- American Board of Pathology Anatomic Pathology
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative ...Alice Y Ho, Stephen Shiao, Samantha A Kobald, Jonathan Chen, Dan G Duda
Journal of Clinical Oncology. 2024-12-20 - 3 citationsAntibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer.Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T Coates, Bogang Wu
Clinical Cancer Research. 2024-07-15 - 1 citationsA dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collabo...Veerle Bossuyt, Elena Provenzano, W Fraser Symmans, Fleur Webster, Kimberly H Allison
Histopathology. 2024-06-01
Press Mentions
Evaluating Post-Treatment Breast SpecimensJanuary 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
